Revenue market share of probiotics and gastrointestinal drugs sold in Spain 2017-2018
This statistic displays the market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, based on revenue and by pharmaceutical company. Over the period of time under consideration, Italfarmaco was the leading provider of these pharmaceutical products in Spain, accounting for almost 18 percent of total units sold within this segment.